Phenibut, also known as β-phenyl-γ-aminobutyric acid, is a neuropsychotropic drug that acts as a GABA-mimetic, primarily targeting GABA(B) receptors and, to a lesser extent, GABA(A) receptors. Initially developed in the Soviet Union in the 1960s, phenibut has been used clinically to alleviate anxiety, tension, and fear, improve sleep, and as a pre- or post-operative medication. It is also prescribed for conditions characterized by asthenia, depression, post-traumatic stress, stuttering, and vestibular disorders.
Phenibut’s structure is similar to that of baclofen, with the key difference being the absence of a chlorine atom in the para-position of the phenyl group. This structural similarity extends to its pharmacological profile, as phenibut exhibits anxiolytic and nootropic (cognitive-enhancing) properties. It stimulates dopamine receptors and antagonizes β-phenethylamine, a putative endogenous anxiogenic.
The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.
| Other Names | 4-Amino-3-phenylbutanoic acid, Fenibut, 4-Amino-3-phenylbutyric acid |
|---|---|
| IUPAC Name | 4-amino-3-phenylbutanoic acid |
| CAS | 1078-21-3 |
| Molecular Weight | 179.22 |
| Molecular Formula | C10H13NO2 |
| SMILES | C1=CC=C(C=C1)C(CC(=O)O)CN |